A pelvic MRI is an imaging test without X-rays that complements ultrasound when ultrasound is not enough. In gynaecology, it is mainly used to map endometriosis, to characterise an ovarian cyst whose nature is uncertain, to assess fibroids or adenomyosis, and to stage certain cancers. It does not replace ultrasound as the first test.
Magnetic resonance imaging (MRI) uses a magnetic field and radio waves to produce detailed images of soft tissues. It does not use X-rays. In the pelvis, it shows the uterus and its different layers, the ovaries, the vagina, the bladder, the rectum and the ligaments connecting them.
In gynaecology, MRI is almost always a second-line test, after a clinical examination and a pelvic ultrasound. It answers a specific question: clarifying an abnormality, mapping before surgery, or assessing how far a disease has spread. It thus helps choose the treatment and, if an operation is needed, plan it (see Gynaecological surgery).
The main indications endorsed by medical societies are as follows.
| Situation | What MRI adds |
|---|---|
| Endometriosis | Detecting and mapping deep lesions (ligaments, vagina, rectum, bladder, ureters) when ultrasound is negative or inconclusive in a woman with symptoms, before surgery, or if symptoms persist after treatment |
| Ovarian cyst or mass that is indeterminate on ultrasound | Characterising the lesion and estimating the risk of cancer using the O-RADS MRI score |
| Fibroids | Precise mapping (number, size, position) before a myomectomy or embolisation |
| Adenomyosis | Showing thickening of the junctional zone and lesions within the wall of the uterus |
| Uterine malformations | Distinguishing a septate, bicornuate or other abnormal uterus, with assessment of the kidneys |
| Gynaecological cancers (cervix, endometrium) | Local staging, which helps choose the treatment |
| Unexplained pelvic pain | Looking for a cause when ultrasound and examination have not found one |
For endometriosis, the European Society of Urogenital Radiology (ESUR) updated its recommendations in 2025: a standardised protocol, a report organised by pelvic compartment, and a classification of lesions to make communication between radiologist, surgeon and patient easier.
About a quarter of ovarian masses seen on ultrasound remain indeterminate: it cannot be said with certainty that they are benign. The O-RADS MRI score grades these masses from 1 to 5 according to their risk of cancer. In a multicentre study in 15 European centres involving 1,130 women, this score had a sensitivity of 93% and a specificity of 91%; no invasive cancer was graded as score 2.
In practice, a low score often allows simple monitoring or conservative surgery, while a high score points towards a team specialising in gynaecological cancer. MRI is the second-line test for masses that ultrasound cannot classify. To find out more: benign ovarian cysts.
You remove any metal objects and lie on your back on a table that slides into a tunnel open at both ends. A coil (antenna) is placed over your pelvis. The scanner is noisy: headphones or earplugs are provided. You stay in contact with the radiographer through a microphone and a call button.
It is important to keep still and follow the breathing instructions. Depending on the protocol, contrast agent is injected into a vein in your arm during the scan, and sometimes a gel is placed in the vagina or rectum to show certain areas better. The duration depends on the protocol; the imaging centre will tell you how long to expect. You can return to your usual activities straight afterwards.
The radiologist writes a report describing each organ, measuring any lesions and, where relevant, grading them with a standardised score (for example O-RADS for an ovarian mass, or a compartment-based classification for endometriosis). A conclusion summarises the key findings.
The report is technical: it only makes full sense alongside your symptoms, the clinical examination and the ultrasound. That is the purpose of the results consultation, which can be booked via Doctolib or by calling 01 43 79 59 79. Depending on the findings, several next steps are possible:
Keep your images and reports: they will be used for comparison at future scans.
MRI does not involve X-rays and has no known risk under normal conditions of use. Reactions to the contrast agent are rare and usually mild (nausea, flushing). Very rarely, a severe allergic reaction can occur, generally during the scan or shortly afterwards, while the team is monitoring you.
Once you are home, if you notice swelling of the face or throat, difficulty breathing or feel faint, call 15 or 112 immediately in France, or your local emergency number.
Yes, as a general rule. Copper and hormonal coils are usually MRI-compatible, but you should always tell the imaging centre before the scan.
Yes, having your period does not prevent an MRI. If your doctor wants the scan at a particular time in your cycle, this will be stated on the referral.
No. Diagnosis is based on symptoms, clinical examination and ultrasound. MRI is useful when ultrasound is inconclusive, before surgery or if symptoms persist after treatment.
An MRI without contrast can be performed during pregnancy if it is useful. Gadolinium injection is avoided unless there is a medical need discussed case by case.
The scan is not painful: the main discomforts are the noise, keeping still and, if needed, the injection into a vein in your arm. How long it takes depends on the protocol and the imaging centre will tell you; you can return to your usual activities straight afterwards.
A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.
Book an appointmentGeneral information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.